"Labetalol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
| Descriptor ID |
D007741
|
| MeSH Number(s) |
D02.033.100.291.460 D02.065.793.324 D02.092.063.291.460
|
| Concept/Terms |
Dilevalol- Dilevalol
- Labetalol, (R,R)-Isomer
- R,R-Labetalol
- R,R Labetalol
|
Below are MeSH descriptors whose meaning is more general than "Labetalol".
Below are MeSH descriptors whose meaning is more specific than "Labetalol".
This graph shows the total number of publications written about "Labetalol" by people in this website by year, and whether "Labetalol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 2 | 0 | 2 |
| 2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Labetalol" by people in Profiles.
-
Asystole during electroconvulsive therapy. J ECT. 2014 Dec; 30(4):259-60.
-
A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy. Am J Obstet Gynecol. 1999 Oct; 181(4):858-61.
-
A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies. Am J Obstet Gynecol. 1999 Oct; 181(4):862-6.
-
Renin profile, race, and antihypertensive efficacy with atenolol and labetalol. J Hum Hypertens. 1991 Jun; 5(3):193-8.
-
Combined alpha/beta-blockade versus beta 1-selective blockade in essential hypertension in black and white patients. Clin Pharmacol Ther. 1990 Dec; 48(6):665-75.
-
[Diazoxide vs. labetalol: a cross-over comparison of acute effects in hypertensive patients (author's transl)]. Lijec Vjesn. 1980 Nov; 102(11):619-23.